SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

AI Briefing

• – SINTX Technologies announces its first-in-human surgery using FDA-cleared SINAPTIC foot and ankle implant, marking entry into the foot and ankle reconstruction market and advancing its silicon nitride biomaterial platform.
• – The company's SINAPTIC implant is designed to provide a more natural feel and improved functionality compared to existing solutions.
• – This milestone marks a significant step towards commercialization of SINTX's biomaterial platform and its expansion into a new market.